Exhaled aerosol increases with COVID-19 infection, age, and obesity
Name
e2021830118.full.pdf
Description
Published version
Size
1.03 MB
Format
Adobe PDF
Checksum (MD5)
985f8983c2a9d9d7aa42e5430f6940d3
Author(s) • • • • • • • • •
Edwards, David A.
Ausiello, Dennis
Salzman, Jonathan
Devlin, Tom
Langer, Robert S
Beddingfield, Brandon J.
Fears, Alyssa C.
Doyle-Meyers, Lara A.
Redmann, Rachel K.
Killeen, Stephanie Z.
Date Issued
February 2021
Journal
Proceedings of the National Academy of Sciences
Publisher
Proceedings of the National Academy of Sciences
Citation
Edwards, David A. et al. "Exhaled aerosol increases with COVID-19 infection, age, and obesity." Proceedings of the National Academy of Sciences 118, 8 (February 2021): e2021830118. © 2021 National Academy of Sciences
Version
Final published version
Abstract
COVID-19 transmits by droplets generated from surfaces of airway mucus during processes of respiration within hosts infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. We studied respiratory droplet generation and exhalation in human and nonhuman primate subjects with and without COVID-19 infection to explore whether SARS-CoV-2 infection, and other changes in physiological state, translate into observable evolution of numbers and sizes of exhaled respiratory droplets in healthy and diseased subjects. In our observational cohort study of the exhaled breath particles of 194 healthy human subjects, and in our experimental infection study of eight nonhuman primates infected, by aerosol, with SARS-CoV-2, we found that exhaled aerosol particles vary between subjects by three orders of magnitude, with exhaled respiratory droplet number increasing with degree of COVID-19 infection and elevated BMI-years. We observed that 18% of human subjects (35) accounted for 80% of the exhaled bioaerosol of the group (194), reflecting a superspreader distribution of bioaerosol analogous to a classical 20:80 superspreader of infection distribution. These findings suggest that quantitative assessment and control of exhaled aerosol may be critical to slowing the airborne spread of COVID-19 in the absence of an effective and widely disseminated vaccine.
MIT Department
Massachusetts Institute of Technology. Department of Chemical Engineering
Massachusetts Institute of Technology. Department of Biological Engineering
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1073/pnas.2021830118